在帕金森病患者衍生的神经元中识别和拯救α-synuclein毒性
Chee Yeun Chung1, Vikram Khurana, Pavan K Auluck
1Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Science (New York, N.Y.)
|October 26, 2013
概括
研究人员使用诱导多能干细胞 (iPS细胞) 来建模帕金森病 (PD),并确定了早期的细胞病理. 一个酵母选分子在患者衍生的神经元中逆转了这些疾病表型.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 诱导多能干细胞 (iPS) 为体外疾病建模提供了潜力.
- 在像帕金森病 (PD) 这样的神经退行性疾病中发现早期细胞病理仍然是一个挑战.
研究的目的:
- 发现和逆转患者衍生的iPS细胞中对α-synuclein (αsyn) 的表型反应.
- 利用从酵母到人类保存的蛋白质毒性机制来识别致病性表型.
主要方法:
- 从患有αsyn突变的患者的iPS细胞生成皮质神经元.
- 从酵母选中使用遗传修饰剂来识别早期的致病性表型.
- 利用了在酵母幕中识别的小分子 (NAB2).
主要成果:
- 在患者神经元中确定了早期的致病性表型,包括化应激,ER相关的降解基质积累和ER应激.
- 证明了小分子NAB2和全方位酶Nedd4可以逆转这些病理表型.
- 在物种中验证了保存的蛋白质毒性机制.
结论:
- 结合跨物种建模的iPS细胞技术,可以揭示早期疾病机制.
- NAB2和Nedd4代表了扭转帕金森病中αsyn诱导病理的潜在治疗点.
- 这种方法有助于发现和逆转神经退行性疾病中的先天细胞病理.
更多相关视频
09:27Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
19.1K
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.5K
相关概念视频
01:24Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34
01:37Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K